|
1.
|
J FerlayHR ShinF BrayD FormanC MathersDM
ParkinEstimates of worldwide burden of cancer in 2008: GLOBOCAN
2008Int J Cancer12728932917201010.1002/ijc.2551621351269
|
|
2.
|
AM Gonzalez-AnguloF Morales-VasquezGN
HortobagyiOverview of resistance to systemic therapy in patients
with breast cancerAdv Exp Med
Biol608122200710.1007/978-0-387-74039-3_117993229
|
|
3.
|
I Ben-PorathMW ThomsonVJ CareyAn embryonic
stem cell-like gene expression signature in poorly differentiated
aggressive human tumorsNat
Genet40499507200810.1038/ng.12718443585
|
|
4.
|
M PesceHR SchölerOct-4: gatekeeper in the
beginnings of mammalian developmentStem
Cells19271278200110.1634/stemcells.19-4-27111463946
|
|
5.
|
DJ RoddaJL ChewLH LimTranscriptional
regulation of nanog by OCT4 and SOX2J Biol
Chem2802473124737200510.1074/jbc.M50257320015860457
|
|
6.
|
UI EzehPJ TurekRA ReijoAT ClarkHuman
embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are
expressed in both seminoma and breast
carcinomaCancer10422552265200510.1002/cncr.2143216228988
|
|
7.
|
AH HartL HartleyK ParkerThe pluripotency
homeobox gene NANOG is expressed in human germ cell
tumorsCancer10420922098200510.1002/cncr.2143516206293
|
|
8.
|
CE Hoei-HansenK AlmstrupJE NielsenStem
cell pluripotency factor NANOG is expressed in human fetal
gonocytes, testicular carcinoma in situ and germ cell
tumoursHistopathology474856200510.1111/j.1365-2559.2005.02182.x15982323
|
|
9.
|
S SantagataJL HornickKL LigonComparative
analysis of germ cell transcription factors in CNS germinoma
reveals diagnostic utility of NANOGAm J Surg
Pathol3016131618200610.1097/01.pas.0000213320.04919.1a17122519
|
|
10.
|
TD JonesTM UlbrightJN EbleLA BaldridgeL
ChengOCT4 staining in testicular tumors: a sensitive and specific
marker for seminoma and embryonal carcinomaAm J Surg
Pathol28935940200410.1097/00000478-200407000-0001415223965
|
|
11.
|
L ChengEstablishing a germ cell origin for
metastatic tumors using OCT4
immunohistochemistryCancer10120062010200410.1002/cncr.2056615386301
|
|
12.
|
K HochedlingerY YamadaC BeardR
JaenischEctopic expression of Oct-4 blocks progenitor-cell
differentiation and causes dysplasia in epithelial
tissuesCell121465477200510.1016/j.cell.2005.02.018
|
|
13.
|
J ZhangX WangB ChenExpression of Nanog
gene promotes NIH3T3 cell proliferationBiochem Biophys Res
Commun33810981102200510.1016/j.bbrc.2005.10.07116259959
|
|
14.
|
CR JeterM BadeauxG ChoyFunctional evidence
that the self-renewal gene NANOG regulates human tumor
developmentStem Cells279931005200910.1002/stem.2919415763
|
|
15.
|
Y SanadaK YoshidaM OharaM OedaK KonishiY
TsutaniHistopathologic evaluation of stepwise progression of
pancreatic carcinoma with immunohistochemical analysis of gastric
epithelial transcription factor SOX2: comparison of expression
patterns between invasive components and cancerous or nonneoplastic
intraductal componentsPancreas321641702006
|
|
16.
|
XL LiY EishiYQ BaiExpression of the
SRY-related HMG box protein SOX2 in human gastric carcinomaInt J
Oncol24257263200414719100
|
|
17.
|
AJ BassH WatanabeCH MermelSOX2 is an
amplified lineage-survival oncogene in lung and esophageal squamous
cell carcinomasNat Genet4112381242200910.1038/ng.46519801978
|
|
18.
|
C LengerkeT FehmR KurthExpression of the
embryonic stem cell marker SOX2 in early-stage breast carcinomaBMC
Cancer1142201110.1186/1471-2407-11-4221276239
|
|
19.
|
SM Rodriguez-PinillaD SarrioG
Moreno-BuenoSox2: a possible driver of the basal-like phenotype in
sporadic breast cancerMod
Pathol20474481200710.1038/modpathol.380076017334350
|
|
20.
|
Y ChenL ShiL ZhangThe molecular mechanism
governing the oncogenic potential of SOX2 in breast cancerJ Biol
Chem2831796917978200810.1074/jbc.M80291720018456656
|
|
21.
|
J LeeHK KimJY RhoYM HanJ KimThe human
OCT-4 isoforms differ in their ability to confer self-renewalJ Biol
Chem2813355433565200610.1074/jbc.M60393720016951404
|
|
22.
|
MH TaiCC ChangM KiupelJD WebsterLK OlsonJE
TroskoOct4 expression in adult human stem cells: evidence in
support of the stem cell theory of
carcinogenesisCarcinogenesis26495502200515513931
|
|
23.
|
JE VisvaderGJ LindemanCancer stem cells in
solid tumours: accumulating evidence and unresolved questionsNat
Rev Cancer8755768200810.1038/nrc249918784658
|
|
24.
|
CC ChangGS ShiehP WuCC LinAL ShiauCL
WuOct-3/4 expression reflects tumor progression and regulates
motility of bladder cancer cellsCancer
Res6862816291200810.1158/0008-5472.CAN-08-009418676852
|
|
25.
|
MM MatinJR WalshPJ GokhaleSpecific
knockdown of Oct4 and beta2-microglobulin expression by RNA
interference in human embryonic stem cells and embryonic carcinoma
cellsStem Cells22659668200410.1634/stemcells.22-5-65915342930
|
|
26.
|
G CauffmanI LiebaersA Van SteirteghemH Van
de VeldePOU5F1 isoforms show different expression patterns in human
embryonic stem cells and preimplantation embryosStem
Cells2426852691200610.1634/stemcells.2005-061116916925
|
|
27.
|
S GidekelG PizovY BergmanE PikarskyOct-3/4
is a dose-dependent oncogenic fate determinantCancer
Cell4361370200310.1016/S1535-6108(03)00270-814667503
|
|
28.
|
LH LooijengaH StoopHP de LeeuwPOU5F1
(OCT3/4) identifies cells with pluripotent potential in human germ
cell tumorsCancer Res6322442250200312727846
|
|
29.
|
Y AtlasiSJ MowlaSA ZiaeeAR BahramiOCT-4,
an embryonic stem cell marker, is highly expressed in bladder
cancerInt J Cancer12015981602200710.1002/ijc.2250817205510
|
|
30.
|
GM SeigelAS HackamA GangulyLM MandellF
Gonzalez-FernandezHuman embryonic and neuronal stem cell markers in
retinoblastomaMol Vis13823832200717615543
|
|
31.
|
SH ChiouCC YuCY HuangPositive correlations
of Oct-4 and Nanog in oral cancer stem-like cells and high-grade
oral squamous cell carcinomaClin Cancer
Res1440854095200810.1158/1078-0432.CCR-07-440418593985
|
|
32.
|
YC ChenHS HsuYW ChenOct-4 expression
maintained cancer stem-like properties in lung cancer-derived
CD133-positive cellsPLoS
One3e2637200810.1371/journal.pone.000263718612434
|
|
33.
|
K OkitaT IchisakaS YamanakaGeneration of
germline-competent induced pluripotent stem
cellsNature448313317200710.1038/nature0593417554338
|
|
34.
|
IH ParkR ZhaoJA WestReprogramming of human
somatic cells to pluripotency with defined
factorsNature451141146200810.1038/nature0653418157115
|
|
35.
|
GJ PanZY ChangHR SchölerD PeiStem cell
pluripotency and transcription factor Oct4Cell
Res12321329200210.1038/sj.cr.729013412528890
|
|
36.
|
H DarrY MaysharN BenvenistyOverexpression
of NANOG in human ES cells enables feeder-free growth while
inducing primitive ectoderm
featuresDevelopment13311931201200610.1242/dev.0228616501172
|
|
37.
|
H ZaehresMW LenschL DaheronSA StewartJ
Itskovitz-EldorGQ DaleyHigh-efficiency RNA interference in human
embryonic stem cellsStem
Cells23299305200510.1634/stemcells.2004-025215749924
|
|
38.
|
L WangP ParkCY LinCharacterization of stem
cell attributes in human osteosarcoma cell linesCancer Biol
Ther8543552200910.4161/cbt.8.6.769519242128
|
|
39.
|
MK SiuES WongHY ChanHY NganKY ChanAN
CheungOverexpression of NANOG in gestational trophoblastic
diseases: effect on apoptosis, cell invasion, and clinical
outcomeAm J
Pathol17311651172200810.2353/ajpath.2008.08028818772339
|
|
40.
|
CT JordanML GuzmanM NobleCancer stem
cellsN Engl J Med35512531261200610.1056/NEJMra06180816990388
|
|
41.
|
L WangP ParkH ZhangF La MarcaCY
LinProspective identification of tumorigenic osteosarcoma cancer
stem cells in OS99-1 cells based on high aldehyde dehydrogenase
activityInt J Cancer128294303201110.1002/ijc.2533120309879
|
|
42.
|
T WilbertzP WagnerK PetersenSOX2 gene
amplification and protein overexpression are associated with better
outcome in squamous cell lung cancerMod
Pathol24944953201110.1038/modpathol.2011.4921460799
|
|
43.
|
C DongD WilhelmP KoopmanSox genes and
cancerCytogenet Genome Res105442447200410.1159/000078217
|
|
44.
|
S SantagataKL LigonJL HornickEmbryonic
stem cell transcription factor signatures in the diagnosis of
primary and metastatic germ cell tumorsAm J Surg
Pathol31836845200710.1097/PAS.0b013e31802e708a17527070
|
